The road to commercializing cell and gene therapies was long, but during the last years we have observed strong market growth and a very crowded pipeline. In this episode, we discuss more challenges and what it takes to successfully launch and commercialize these advanced therapies.

Hosted by: Jennifer Curtis

Produced by: Matilda Males

Featuring: Sankalp Sethi

In light of World AIDS Day 2021, in this episode of ‘Inside Global Pharma’ we focus on the journey to eradicating AIDS and discuss themes of inequality today and how they can be managed.

Hosted by: Jennifer Curtis

Produced by: Matilda Males and Sophie McManus

Featuring: Mark Saunders and Bill Coyle

We immersed ourselves in R&D to discuss what drives clinical trial success beyond the science alone. Join us to learn what it means to be human-centric in the context of clinical trials, and how human-centric principles and cognitive science can aid trial recruitment and execution.

Hosted by: Jennifer Curtis

Produced by: Matilda Males and Sophie McManus

Featuring: Chris Crabtree and Jacob Braude

In this episode we are exploring the role of medical affairs in shaping stakeholder engagement strategies across both traditional and digital channels and what this means for the future of medical affairs.

Hosted by: Jennifer Curtis

Produced by: Matilda Males

Featuring: Bora Erdemli and Sarah Jarvis

Customer engagement has been a hot topic across pharma med tech companies, even before the pandemic. In this episode, we discuss the future of customer engagement and how can companies deliver consistent, relevant, and positive experience in digital, in-person and hybrid world.

Hosted by: Jennifer Curtis

Produced by: Matilda Males

Featuring: Jude Konzelmann and Heather Wiederholt

In this episode, our guest is Josh Hattem discussing insights from recent research on the value of focus in portfolio strategy for biopharmaceutical companies. Highlights from the episode include:

- Defining what is a portfolio strategy within a biopharmaceutical company

- Why focus can provide a competitive edge but companies often fail to maximize the benefits

- Implications on how to align R&D and commercial strategy to drive pipeline investment and greater commercial success 

Additional details – Article published on InVivo (March 2021) https://invivo.pharmaintelligence.informa.com/IV124716/The-Value-And-Challenge-Of-Focus-In-Pharma

Hosted by: Jennifer Curtis

Produced by: Matilda Males

Featuring: Joshua Hattem

COVID-19 has pushed the idea of scenario planning to the forefront. It is becoming increasingly important to be able to anticipate and plan for the unexpected by looking at the extremes, and how they could change the business. In this episode we focus on oncology and discuss three different worlds that could emerge in the future and implications on pharma’s business strategy.

Hosted by: Matilda Males

Produced by: Matilda Males

Featuring: Jennifer Curtis and Malik Kaman

Cancer has been progressively redefined over the past 20 years. One of the most active pipelines is immunotherapy, with almost 300 molecules in phase one or phase two trials. In this episode we are discussing if existing immunotherapies have lived up to the expectations and what will drive success for the next wave of products in this evolving market.

Hosted by: Jennifer Curtis

Produced by: Matilda Males and Rohan Giblin

Featuring: Malik Kaman, Jon Roffman, Sharon Karlsberg

COVID-19 has accelerated many trends that were only starting to emerge in healthcare before 2020. It led to an inflection point, bringing in new opportunities and challenges in how pharma and medtech companies serve patients and other customers. Here, we set to explore COVID-19 not just as a unique event and implications specific to it, but more as the wider trends we anticipate playing out and how pharma and medtech companies need to prepare and invest to win in the future.

Hosted by: Jennifer Curtis

Produced by: Matilda Males

Featuring: Brian Chapman, David Jackson, Mark Saunders

Patient centricity is a topic that has been floating around healthcare organizations for the better part of the last decade. Most healthcare companies have something about patients in their mission statement or vision. However, although the patients are the ultimate customers in the healthcare landscape, they may not always be in the forefront. In this episode we talk with two ZS leaders to hear their perspective on what patient centricity really means and what organizations can do today to become more patient centric.

Hosted by: Jennifer Curtis

Produced by: Matilda Males and Rohan Giblin

Featuring: Hensley Evans, Gordon Bache